vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and FiscalNote Holdings, Inc. (NOTE). Click either name above to swap in a different company.

ARVINAS, INC. is the larger business by last-quarter revenue ($41.9M vs $22.2M, roughly 1.9× FiscalNote Holdings, Inc.). On growth, FiscalNote Holdings, Inc. posted the faster year-over-year revenue change (-24.7% vs -59.1%). FiscalNote Holdings, Inc. produced more free cash flow last quarter ($-1.9M vs $-59.2M). Over the past eight quarters, ARVINAS, INC.'s revenue compounded faster (10.0% CAGR vs -16.8%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

FiscalNote Holdings, Inc., or commonly FiscalNote, is a publicly traded software, data, and media company headquartered in Washington, D.C. The company was founded by Timothy Hwang, Gerald Yao, and Jonathan Chen in 2013. FiscalNote provides software tools, platforms, data services, and news through the FiscalNote Government Relationship Management (GRM) service, its core product. The company also uses an artificial intelligence platform to analyze proposed U.S. legislation based on key phrase...

ARVN vs NOTE — Head-to-Head

Bigger by revenue
ARVN
ARVN
1.9× larger
ARVN
$41.9M
$22.2M
NOTE
Growing faster (revenue YoY)
NOTE
NOTE
+34.4% gap
NOTE
-24.7%
-59.1%
ARVN
More free cash flow
NOTE
NOTE
$57.3M more FCF
NOTE
$-1.9M
$-59.2M
ARVN
Faster 2-yr revenue CAGR
ARVN
ARVN
Annualised
ARVN
10.0%
-16.8%
NOTE

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
NOTE
NOTE
Revenue
$41.9M
$22.2M
Net Profit
$-35.1M
Gross Margin
Operating Margin
-104.5%
-83.7%
Net Margin
-83.8%
Revenue YoY
-59.1%
-24.7%
Net Profit YoY
28.7%
EPS (diluted)
$-0.48
$-2.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
NOTE
NOTE
Q4 25
$22.2M
Q3 25
$41.9M
$22.4M
Q2 25
$23.3M
Q1 25
$188.8M
$27.5M
Q4 24
$59.2M
$29.5M
Q3 24
$102.4M
$29.4M
Q2 24
$76.5M
$29.2M
Q1 24
$25.3M
$32.1M
Net Profit
ARVN
ARVN
NOTE
NOTE
Q4 25
Q3 25
$-35.1M
$-24.9M
Q2 25
$-13.3M
Q1 25
$82.9M
$-4.3M
Q4 24
$-45.1M
Q3 24
$-49.2M
$-14.9M
Q2 24
$-35.2M
$-12.8M
Q1 24
$-69.4M
$50.6M
Operating Margin
ARVN
ARVN
NOTE
NOTE
Q4 25
-83.7%
Q3 25
-104.5%
-43.4%
Q2 25
-31.9%
Q1 25
37.8%
-50.0%
Q4 24
-98.1%
-19.4%
Q3 24
-58.9%
-23.1%
Q2 24
-63.4%
-27.2%
Q1 24
-329.2%
-35.6%
Net Margin
ARVN
ARVN
NOTE
NOTE
Q4 25
Q3 25
-83.8%
-110.8%
Q2 25
-57.0%
Q1 25
43.9%
-15.4%
Q4 24
-76.2%
Q3 24
-48.0%
-50.7%
Q2 24
-46.0%
-43.6%
Q1 24
-274.3%
157.6%
EPS (diluted)
ARVN
ARVN
NOTE
NOTE
Q4 25
$-2.81
Q3 25
$-0.48
$-1.73
Q2 25
$-0.08
Q1 25
$1.14
$-0.03
Q4 24
$-0.63
$1.88
Q3 24
$-0.68
$-1.33
Q2 24
$-0.49
$-0.09
Q1 24
$-0.97
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
NOTE
NOTE
Cash + ST InvestmentsLiquidity on hand
$787.6M
$26.3M
Total DebtLower is stronger
$600.0K
$128.4M
Stockholders' EquityBook value
$564.4M
$62.0M
Total Assets
$844.3M
$255.1M
Debt / EquityLower = less leverage
0.00×
2.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
NOTE
NOTE
Q4 25
$26.3M
Q3 25
$787.6M
$31.2M
Q2 25
$38.5M
Q1 25
$954.3M
$46.3M
Q4 24
$1.0B
$34.6M
Q3 24
$1.1B
$32.7M
Q2 24
$1.2B
$37.7M
Q1 24
$1.2B
$43.6M
Total Debt
ARVN
ARVN
NOTE
NOTE
Q4 25
$128.4M
Q3 25
$600.0K
$131.5M
Q2 25
$116.7M
Q1 25
$700.0K
$118.0M
Q4 24
$800.0K
$147.1M
Q3 24
$800.0K
$152.2M
Q2 24
$900.0K
$145.9M
Q1 24
$900.0K
$153.0M
Stockholders' Equity
ARVN
ARVN
NOTE
NOTE
Q4 25
$62.0M
Q3 25
$564.4M
$75.5M
Q2 25
$95.1M
Q1 25
$660.1M
$98.7M
Q4 24
$561.7M
$97.8M
Q3 24
$586.0M
$98.5M
Q2 24
$600.2M
$106.9M
Q1 24
$609.7M
$106.1M
Total Assets
ARVN
ARVN
NOTE
NOTE
Q4 25
$255.1M
Q3 25
$844.3M
$273.9M
Q2 25
$288.3M
Q1 25
$1.0B
$299.7M
Q4 24
$1.1B
$326.2M
Q3 24
$1.2B
$337.9M
Q2 24
$1.3B
$346.3M
Q1 24
$1.2B
$357.8M
Debt / Equity
ARVN
ARVN
NOTE
NOTE
Q4 25
2.07×
Q3 25
0.00×
1.74×
Q2 25
1.23×
Q1 25
0.00×
1.20×
Q4 24
0.00×
1.50×
Q3 24
0.00×
1.54×
Q2 24
0.00×
1.36×
Q1 24
0.00×
1.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
NOTE
NOTE
Operating Cash FlowLast quarter
$-59.1M
$-279.0K
Free Cash FlowOCF − Capex
$-59.2M
$-1.9M
FCF MarginFCF / Revenue
-141.3%
-8.7%
Capex IntensityCapex / Revenue
0.2%
7.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$-18.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
NOTE
NOTE
Q4 25
$-279.0K
Q3 25
$-59.1M
$-8.3M
Q2 25
$-6.2M
Q1 25
$-88.9M
$3.3M
Q4 24
$-84.1M
$-1.3M
Q3 24
$-128.0M
$-3.0M
Q2 24
$50.3M
$-3.7M
Q1 24
$-97.5M
$2.7M
Free Cash Flow
ARVN
ARVN
NOTE
NOTE
Q4 25
$-1.9M
Q3 25
$-59.2M
$-10.4M
Q2 25
$-7.7M
Q1 25
$-89.3M
$1.3M
Q4 24
$-84.4M
$-3.4M
Q3 24
$-128.7M
$-5.4M
Q2 24
$49.6M
$-6.5M
Q1 24
$-97.6M
$1.0M
FCF Margin
ARVN
ARVN
NOTE
NOTE
Q4 25
-8.7%
Q3 25
-141.3%
-46.2%
Q2 25
-33.0%
Q1 25
-47.3%
4.7%
Q4 24
-142.6%
-11.4%
Q3 24
-125.7%
-18.4%
Q2 24
64.8%
-22.1%
Q1 24
-385.8%
3.3%
Capex Intensity
ARVN
ARVN
NOTE
NOTE
Q4 25
7.4%
Q3 25
0.2%
9.3%
Q2 25
6.4%
Q1 25
0.2%
7.2%
Q4 24
0.5%
6.8%
Q3 24
0.7%
8.3%
Q2 24
0.9%
9.4%
Q1 24
0.4%
5.3%
Cash Conversion
ARVN
ARVN
NOTE
NOTE
Q4 25
Q3 25
Q2 25
Q1 25
-1.07×
Q4 24
Q3 24
Q2 24
Q1 24
0.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARVN
ARVN

Segment breakdown not available.

NOTE
NOTE

Subscription$21.2M95%
Advisory Advertising And Other$1.0M5%

Related Comparisons